Managlinatum Dialanetilum

Managlinatum Dialanetilum Uses, Dosage, Side Effects, Food Interaction and all others data.

CS-917 is a novel inhibitor of fructose 1,6-bisphphosphatase (FBPase) which is one of the rate-limiting enzymes of gluconeogenesis.

Table Of contents

• Managlinatum Dialanetilum
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Managlinatum Dialanetilum
Generic	Managlinat dialanetil
Managlinat dialanetil Other Names	Managlinat dialanetil, Managlinat dialanétil, Managlinat dialanetilo, Managlinatum dialanetilum
Type
Formula	C21H33N4O6PS
Weight	Average: 500.55 Monoisotopic: 500.185842971
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in diabetes mellitus type 2.

How Managlinatum Dialanetilum works

In type 2 diabetes, the liver produces excessive amounts of glucose through the gluconeogenesis (GNG) pathway and consequently is partly responsible for the elevated glucose levels characteristic of the disease. CS-917 targets the AMP binding site of fructose 1,6-bisphosphatase (FBPase), inhibiting the GNC pathway.

Innovators Monograph

You find simplified version here Managlinatum Dialanetilum